• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    DoD-Funded BioXcel Advances BXCL501 for Stress Relief

    GLOBENEWSWIRE

    BioXcel Gets FDA Acceptance for IGALMI At-Home Use sNDA

    GLOBENEWSWIRE

    BioXcel Therapeutics Reports Fourth Quarter and Financial Results

    GLOBENEWSWIRE

    Bioxcel Therapeutics Closes $8M Direct Offering

    GLOBENEWSWIRE

    Bioxcel Therapeutics Reveals $8M Registered Direct Offering

    GLOBENEWSWIRE

    Bioxcel Therapeutics Reports Positive Phase 2 Results

    GLOBENEWSWIRE

    Bioxcel Therapeutics Hosts Virtual Roundtable On Acute Agitation

    GLOBENEWSWIRE

    Bioxcel Therapeutics Advances IGALMI Commercialization Plan

    GLOBENEWSWIRE

    Bioxcel Seeks Fda Approval For IGALMI At-Home Label Expansion

    GLOBENEWSWIRE

    Bioxcel Therapeutics Boosts Leadership For IGALMI At-Home Launch

    GLOBENEWSWIRE

    Bioxcel Therapeutics To Seek FDA Approval For IGALMI At-Home Use

    GLOBENEWSWIRE

    BioXcel Reports Positive SERENITY At-Home Correlation Study

    GLOBENEWSWIRE

    Bioxcel Therapeutics To Mark Neuroscience Innovation Milestone

    GLOBENEWSWIRE

    BioXcel Therapeutics Publishes Study on Dexmedetomidine Effects

    GLOBENEWSWIRE

    Biocel Wraps up Serenity Trial for Treating Agitation

    GLOBENEWSWIRE

    BioXcel Submits Pre-Supplemental Drug App for IGALMI Expansion

    GLOBENEWSWIRE

    BioXcel Therapeutics boosts cash to advance SERENITY trial

    GLOBENEWSWIRE

    BioXcel Therapeutics Announces Closes $14M Offering

    GLOBENEWSWIRE

    BioXcel`s BXCL701+KEYTRUDA in PDAC Data at ASCO 2024

    GLOBENEWSWIRE

    BioXcel Reports Positive Overall Survival Results form Phase 2 Trial of BXCL701

    GLOBENEWSWIRE

    BioXcel Reports Positive Overall Survival Results from Phase 2 Trial of BXCL701

    GLOBENEWSWIRE

    BioXcel reports data from study of rare prostate cancer therapy

    CLINICAL TRIALS ARENA

    BioXcel teases phase 2 Keytruda combination trial data drop

    FIERCE BIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.